Perdoceo Education (PRDO) is a Great Momentum Stock: Should You Buy? — Positive
PRDO Zacks Investment Research — May 23, 2025Does Perdoceo Education (PRDO) have what it takes to be a top stock pick for momentum investors? Let's find out.
Allient (ALNT) is a Great Momentum Stock: Should You Buy? — Positive
ALNT Zacks Investment Research — May 23, 2025Does Allient (ALNT) have what it takes to be a top stock pick for momentum investors? Let's find out.
atai Life Sciences N.V. (ATAI) Is Up 18.71% in One Week: What You Should Know — Positive
ATAI Zacks Investment Research — May 23, 2025Does atai Life Sciences N.V. (ATAI) have what it takes to be a top stock pick for momentum investors?
Seres Therapeutics (MCRB) Upgraded to Buy: What Does It Mean for the Stock? — Positive
MCRB Zacks Investment Research — May 23, 2025Seres Therapeutics (MCRB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Domo (DOMO) is a Great Momentum Stock: Should You Buy? — Positive
DOMO Zacks Investment Research — May 23, 2025Does Domo (DOMO) have what it takes to be a top stock pick for momentum investors? Let's find out.
What Makes Relay Therapeutics (RLAY) a New Buy Stock — Positive
RLAY Zacks Investment Research — May 23, 2025Relay Therapeutics (RLAY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Fathom Holdings (FTHM) Moves to Buy: Rationale Behind the Upgrade — Positive
FTHM Zacks Investment Research — May 23, 2025Fathom Holdings (FTHM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Exelixis (EXEL) Upgraded to Buy: What Does It Mean for the Stock? — Positive
EXEL Zacks Investment Research — May 23, 2025Exelixis (EXEL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
All You Need to Know About First Commonwealth Financial (FCF) Rating Upgrade to Buy — Positive
FCF Zacks Investment Research — May 23, 2025First Commonwealth Financial (FCF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
All You Need to Know About Commerce (CBSH) Rating Upgrade to Buy — Positive
CBSH Zacks Investment Research — May 23, 2025Commerce (CBSH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Solitario (XPL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
All You Need to Know About Nerdy (NRDY) Rating Upgrade to Buy — Positive
NRDY Zacks Investment Research — May 23, 2025Nerdy (NRDY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
What Makes Eledon Pharmaceuticals (ELDN) a New Buy Stock — Positive
ELDN Zacks Investment Research — May 23, 2025Eledon Pharmaceuticals (ELDN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Mondelez (MDLZ) Upgraded to Strong Buy: Here's What You Should Know — Positive
MDLZ Zacks Investment Research — May 23, 2025Mondelez (MDLZ) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Why J.Jill (JILL) Could Beat Earnings Estimates Again — Positive
JILL Zacks Investment Research — May 23, 2025J.Jill (JILL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Royal Bank (RY) Beat Estimates Again in Its Next Earnings Report? — Positive
RY Zacks Investment Research — May 23, 2025Royal Bank (RY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Is Unum Group Stock Worth Buying Post its Recent Dividend Hike — Positive
UNM Zacks Investment Research — May 23, 2025Unum Group boosts dividend 10% as it eyes $300-$330 million payout in 2025, but analysts remain cautious amid high valuation and tepid earnings outlook.
Earnings Estimates Moving Higher for Exelixis (EXEL): Time to Buy? — Positive
EXEL Zacks Investment Research — May 23, 2025Exelixis (EXEL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Should You Hold on to RDDT Despite the Stock's 39% YTD Decline? — Neutral
RDDT Zacks Investment Research — May 23, 2025Reddit stock benefits from ad business growth, AI initiatives, and new partnerships, but faces stiff competition and valuation concerns.
IBM vs. Accenture: Which Stock Stands Out in the Consulting Game? — Positive
ACN IBM Zacks Investment Research — May 23, 2025IBM and ACN battle for consulting dominance as AI, cloud and strategic collaborations reshape enterprise digital transformation strategies.
